Infiltrating CTLs in human glioblastoma establish immunological synapses with tumorigenic cells

American Journal of Pathology

Volumn 175, Issue 2, 2009, Pages 786-798

  Barcia Jr , Carlos ^a   Gómez, Aurora ^a   Gallego Sanchez, José M ^b   Perez Vallés, Ana ^b   Castro, Maria G ^c,d   Lowenstein, Pedro R ^c,d   Barcia Sr , Carlos ^b   Herrero, Maria Trinidad ^a  

^a UNIVERSITY OF MURCIA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c CEDARS SINAI MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; CASPASE 3; CD3 ANTIGEN; GRANZYME B;

ARTICLE; ASTROCYTOMA; BLOOD ANALYSIS; CASE REPORT; CELL COMMUNICATION; CELL DEATH; CELL INFILTRATION; CELL INTERACTION; CELL POLARITY; CELL STRUCTURE; CONFOCAL MICROSCOPY; CYTOSKELETON; CYTOTOXIC T LYMPHOCYTE; GLIOBLASTOMA; HUMAN; IMMUNE SYSTEM; IMMUNOCYTOCHEMISTRY; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; IMMUNOTHERAPY; LEUKOCYTOSIS; NEUROIMAGING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROSCOPY; SYNAPSE; TARGET CELL; TUMOR CELL;

EID: 68449093354     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2009.081034     Document Type: Article

References (47)

1. Bossi G, Griffiths GM: CTL secretory lysosomes: biogenesis and secretion of a harmful organelle. Semin Immunol 2005, 17:87-94
2. Stinchcombe JC, Bossi G, Booth S, Griffiths GM: The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 2001, 15:751-761
3. Stinchcombe JC, Griffiths GM: The role of the secretory immunological synapse in killing by CD8+ CTL. Semin Immunol 2003, 15:301-305
4. Barcia C, Thomas CE, Curtin JF, King GD, Wawrowsky K, Candolfi M, Xiong WD, Liu C, Kroeger K, Boyer O, Kupiec-Weglinski J, Klatzmann D, Castro MG, Lowenstein PR: In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brain. J Exp Med 2006, 203:2095-2107
5. Combs J, Kim SJ, Tan S, Ligon LA, Holzbaur EL, Kuhn J, Poenie M: Recruitment of dynein to the Jurkat immunological synapse. Proc Natl Acad Sci USA: 2006, 103:14883-14888
6. Monks CR, Freiberg BA, Kupfer H, Sciaky N, Kupfer A: Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 1998, 395:82-86
7. Stinchcombe JC, Majorovits E, Bossi G, Fuller S, Griffiths GM: Centrosome polarization delivers secretory granules to the immunological synapse. Nature 2006, 443:462-465
8. Kuhn JR, Poenie M: Dynamic polarization of the microtubule cytoskeleton during CTL-mediated killing. Immunity 2002, 16:111-121
9. Dustin ML: A dynamic view of the immunological synapse. Semin Immunol 2005, 17:400-410
10. Lieberman J: The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol 2003, 3:361-370
11. Yokosuka T, Sakata-Sogawa K, Kobayashi W, Hiroshima M, Hashimoto-Tane A, Tokunaga M, Dustin ML, Saito T: Newly generated T cell receptor microclusters initiate and sustain T cell activation by recruitment of Zap70 and SLP-76. Nat Immunol 2005, 6:1253-1262
12. Kaizuka Y, Douglass AD, Varma R, Dustin ML, Vale RD: Mechanisms for segregating T cell receptor and adhesion molecules during immunological synapse formation in Jurkat T cells. Proc Natl Acad Sci USA 2007, 104:20296-20301
13. Carpentier AF, Meng Y: Recent advances in immunotherapy for human glioma. Curr Opin Oncol 2006, 18:631-636
14. Egen JG, Kuhns MS, Allison JP: CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 2002, 3:611-618
15. Boissonnas A, Fetler L, Zeelenberg IS, Hugues S, Amigorena S: In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor. J Exp Med 2007, 204:345-356
16. Breart B, Lemaitre F, Celli S, Bousso P: Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice. J Clin Invest 2008, 118:1390-1397
17. Mrass P, Takano H, Ng LG, Daxini S, Lasaro MO, Iparraguirre A, Cavanagh LL, von Andrian UH, Ertl HC, Haydon PG, Weninger W: Random migration precedes stable target cell interactions of tumor-infiltrating T cells. J Exp Med 2006, 203:2749-2761
18. Barcia C, Jimenez-Dalmaroni M, Kroeger KM, Puntel M, Rapaport AJ, Larocque D, King GD, Johnson SA, Liu C, Xiong W, Candolfi M, Mondkar S, Ng P, Palmer D, Castro MG, Lowenstein PR: One-year expression from high-capacity adenoviral vectors in the brains of animals with pre-existing anti-adenoviral immunity: clinical implications. Mol Ther 2007, 15:2154-2163
19. Thomas CE, Abordo-Adesida E, Maleniak TC, Stone D, Gerdes, G, Lowenstein PR: Gene transfer into rat brain using adenoviral vectors. Edited by JN Gerfen, R McKay, MA Rogawski, DR Sibley, and P Skolnick. New York NY, John Wiley and Sons, New York, 2000, pp. 4.23.21-24.23.40
20. Barcia C, Wawrowsky K, Barrett RJ, Liu C, Castro MG, Lowenstein PR: In vivo polarization of IFN-{gamma} at Kupfer and non-Kupfer immunological synapses during the clearance of virally infected brain cells. J Immunol 2008, 180:1344-1352
21. Barcia C, Sanchez Bahillo A, Fernandez-Villalba E, Bautista V, Poza YPM, Fernandez-Barreiro A, Hirsch EC, Herrero MT: Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure. Glia 2004, 46:402-409
22. Sterio DC: The unbiased estimation of number and sizes of arbitrary particles using the dissector. J Microsc 1984, 134 (Pt 2):127-136
23. Barcia C, Gomez A, de Pablos V, Fernandez-Villalba E, Liu C, Kroeger KM, Martin J, Barreiro AF, Castro MG, Lowenstein PR, Herrero MT: CD20, CD3, and CD40 ligand microclusters segregate three-dimensionally in vivo at B-cell-T-cell immunological synapses after viral immunity in primate brain. J Virol 2008, 82:9978-9993
24. Mor-Vaknin N, Punturieri A, Sitwala K, Markovitz DM: Vimentin is secreted by activated macrophages. Nat Cell Biol 2003, 5:59-63
25. Cao X, Cai SF, Fehniger TA, Song J, Collins LI, Piwnica-Worms DR, Ley TJ: Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance. Immunity 2007, 27:635-646
26. Martin-Cofreces NB, Sancho D, Fernandez E, Vicente-Manzanares M, Gordon-Alonso M, Montoya MC, Michel F, Acuto O, Alarcon B, Sanchez-Madrid F: Role of Fyn in the rearrangement of tubulin cytoskeleton induced through TCR. J Immunol 2006, 176:4201-4207
27. Adrain C, Duriez PJ, Brumatti G, Delivani P, Martin SJ: The cytotoxic lymphocyte protease, granzyme B, targets the cytoskeleton and perturbs microtubule polymerization dynamics. J Biol Chem 2006, 281:8118-8125
28. Goping IS, Sawchuk T, Underhill DA, Bleackley RC: Identification of {alpha}-tubulin as a granzyme B substrate during CTL-mediated apoptosis. J Cell Sci 2006, 119:858-865
29. Waterhouse NJ, Oliaro J, Pinkoski MJ: A 'polarized' look at alpha-tubulin cleavage by granzyme B. Cell Death Differ 2006, 13:1839-1841
30. Blanchard N, Di Bartolo V, Hivroz C: In the immune synapse. ZAP-70 controls T cell polarization and recruitment of signaling proteins but not formation of the synaptic pattern. Immunity 2002, 17:389-399
31. Nolz JC, Gomez TS, Zhu P, Li S, Medeiros RB, Shimizu Y, Burkhardt JK, Freedman BD, Billadeau DD: The WAVE2 complex regulates actin cytoskeletal reorganization and CRAC-mediated calcium entry during T cell activation. Curr Biol 2006, 16:24-34
32. Huang Y, Burkhardt JK: T-cell-receptor-dependent actin regulatory mechanisms. J Cell Sci 2007, 120:723-730
33. Stohlman SA, Bergmann CC, Lin MT, Cua DJ, Hinton DR: CTL effector function within the central nervous system requires CD4+ T cells. J Immunol 1998, 160:2896-2904
34. Kupfer A, Dennert G, Singer SJ: The reorientation of the Golgi apparatus and the microtubule-organizing center in the cytotoxic effector cell is a prerequisite in the lysis of bound target cells. J Mol Cell Immunol 1985, 2:37-49
35. Lin J, Miller MJ, Shaw AS: The c-SMAC: sorting it all out (or in). J Cell Biol 2005, 170:177-182
36. Somersalo K, Anikeeva N, Sims TN, Thomas VK, Strong RK, Spies T, Lebedeva T, Sykulev Y, Dustin ML: Cytotoxic T lymphocytes form an antigen-independent ring junction. J Clin Invest 2004, 113:49-57
37. Bredemeyer AJ, Lewis RM, Malone JP, Davis AE, Gross J, Townsend RR, Ley TJ: A proteomic approach for the discovery of protease substrates. Proc Natl Acad Sci USA 2004, 101:11785-11790
38. Sahin U, Tureci O, Pfreundschuh M: Serological identification of human tumor antigens. Curr Opin Immunol 1997, 9:709-716
39. Radoja S, Saio M, Schaer D, Koneru M, Vukmanovic S, Frey AB: CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis. J Immunol 2001, 167:5042-5051
40. Fecci PE, Mitchell DA, Whitesides JF, Xie W, Friedman AH, Archer GE, Herndon JE, 2nd, Bigner DD, Dranoff G, Sampson JH: Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma. Cancer Res 2006, 66:3294-3302
41. Learn CA, Fecci PE, Schmittling RJ, Xie W, Karikari I, Mitchell DA, Archer GE, Wei Z, Dressman H, Sampson JH: Profiling of CD4+, CD8+, and CD4+CD25+CD45RO+FoxP3+ T cells in patients with malignant glioma reveals differential expression of the immunologic transcriptome compared with T cells from healthy volunteers. Clin Cancer Res 2006, 12:7306-7315
42. Parsa AT, Waldron JS, Panner A, Crane CA, Parney IF, Barry JJ, Cachola KE, Murray JC, Tihan T, Jensen MC, Mischel PS, Stokoe D, Pieper RO: Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma. Nat Med 2007, 13:84-88
43. Piconese S, Valzasina B, Colombo MP: OX40 triggering blocks suppression by regulatory T cells and facilitates tumor rejection. J Exp Med 2008, 205:825-839
44. Stephan MT, Ponomarev V, Brentjens RJ, Chang AH, Dobrenkov KV, Heller G, Sadelain M: T cell-encoded CD80 and 4-1BBL induce autoand transcostimulation, resulting in potent tumor rejection. Nat Med 2007, 13:1440-1449
45. Curtin JF, King GD, Candolfi M, Greeno RB, Kroeger KM, Lowenstein PR, Castro MG: Combining cytotoxic and immune-mediated gene therapy to treat brain tumors. Curr Top Med Chem 2005, 5:1151-1170
46. King GD, Curtin JF, Candolfi M, Kroeger K, Lowenstein PR, Castro MG: Gene therapy and targeted toxins for glioma. Curr Gene Ther 2005, 5:535-557
47. King GD, Muhammad AK, Curtin JF, Barcia C, Puntel M, Liu C, Honig SB, Candolfi M, Mondkar S, Lowenstein PR, Castro MG: Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model. Neuro Oncol 2008, 10:19-31